Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Marrow-isolated adult multilineage inducible cells embedded within a biologically-inspired construct promote recovery in a mouse model of peripheral vascular disease.

Grau-Monge C, Delcroix GJ, Bonnin-Marquez A, Valdes M, Awadallah EL, Quevedo DF, Armour MR, Montero RB, Schiller PC, Andreopoulos FM, D'Ippolito G.

Biomed Mater. 2017 Feb 17;12(1):015024. doi: 10.1088/1748-605X/aa5a74.

PMID:
28211362
2.

Improving the therapeutic efficacy of mesenchymal stromal cells to restore perfusion in critical limb ischemia through pulsed focused ultrasound.

Tebebi PA, Kim SJ, Williams RA, Milo B, Frenkel V, Burks SR, Frank JA.

Sci Rep. 2017 Feb 7;7:41550. doi: 10.1038/srep41550.

3.

Multipotent adult progenitor cells on an allograft scaffold facilitate the bone repair process.

LoGuidice A, Houlihan A, Deans R.

J Tissue Eng. 2016 Jul 8;7:2041731416656148. doi: 10.1177/2041731416656148. eCollection 2016 Jan-Dec.

4.

Therapeutic assessment of mesenchymal stem cells delivered within a PEGylated fibrin gel following an ischemic injury.

Ricles LM, Hsieh PL, Dana N, Rybalko V, Kraynak C, Farrar RP, Suggs LJ.

Biomaterials. 2016 Sep;102:9-19. doi: 10.1016/j.biomaterials.2016.06.011. Epub 2016 Jun 7.

PMID:
27318932
5.

Monitoring the Bystander Killing Effect of Human Multipotent Stem Cells for Treatment of Malignant Brain Tumors.

Leten C, Trekker J, Struys T, Roobrouck VD, Dresselaers T, Vande Velde G, Lambrichts I, Verfaillie CM, Himmelreich U.

Stem Cells Int. 2016;2016:4095072. doi: 10.1155/2016/4095072. Epub 2016 Jan 6.

6.

Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury.

DePaul MA, Palmer M, Lang BT, Cutrone R, Tran AP, Madalena KM, Bogaerts A, Hamilton JA, Deans RJ, Mays RW, Busch SA, Silver J.

Sci Rep. 2015 Nov 19;5:16795. doi: 10.1038/srep16795.

7.

Stem Cells for Cutaneous Wound Healing.

Kirby GT, Mills SJ, Cowin AJ, Smith LE.

Biomed Res Int. 2015;2015:285869. doi: 10.1155/2015/285869. Epub 2015 Jun 2. Review.

8.
9.

Echocardiographic evaluation of the effects of stem cell therapy on perfusion and function in ischemic cardiomyopathy.

Inaba Y, Davidson BP, Kim S, Liu YN, Packwood W, Belcik JT, Xie A, Lindner JR.

J Am Soc Echocardiogr. 2014 Feb;27(2):192-9. doi: 10.1016/j.echo.2013.10.011. Epub 2013 Dec 4.

10.

Biomarker-free dielectrophoretic sorting of differentiating myoblast multipotent progenitor cells and their membrane analysis by Raman spectroscopy.

Muratore M, Srsen V, Waterfall M, Downes A, Pethig R.

Biomicrofluidics. 2012 Aug 13;6(3):34113. doi: 10.1063/1.4746252. Print 2012 Sep.

11.

Bone marrow mononuclear cells exert long-term neuroprotection in a rat model of ischemic stroke by promoting arteriogenesis and angiogenesis.

Wang J, Yu L, Jiang C, Chen M, Ou C, Wang J.

Brain Behav Immun. 2013 Nov;34:56-66. doi: 10.1016/j.bbi.2013.07.010. Epub 2013 Jul 24.

12.

Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks (Review).

Katoh M.

Int J Mol Med. 2013 Oct;32(4):763-7. doi: 10.3892/ijmm.2013.1444. Epub 2013 Jul 16. Review.

13.

Molecular imaging of the paracrine proangiogenic effects of progenitor cell therapy in limb ischemia.

Ryu JC, Davidson BP, Xie A, Qi Y, Zha D, Belcik JT, Caplan ES, Woda JM, Hedrick CC, Hanna RN, Lehman N, Zhao Y, Ting A, Lindner JR.

Circulation. 2013 Feb 12;127(6):710-9. doi: 10.1161/CIRCULATIONAHA.112.116103. Epub 2013 Jan 10.

14.

Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells.

Jacobs SA, Roobrouck VD, Verfaillie CM, Van Gool SW.

Immunol Cell Biol. 2013 Jan;91(1):32-9. doi: 10.1038/icb.2012.64. Review.

15.

Application of MultiStem(®) Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease.

Vaes B, Van't Hof W, Deans R, Pinxteren J.

Front Immunol. 2012 Nov 27;3:345. doi: 10.3389/fimmu.2012.00345. eCollection 2012.

16.

Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice.

Mora-Lee S, Sirerol-Piquer MS, Gutiérrez-Pérez M, Gomez-Pinedo U, Roobrouck VD, López T, Casado-Nieto M, Abizanda G, Rabena MT, Verfaille C, Prósper F, García-Verdugo JM.

PLoS One. 2012;7(8):e43683. doi: 10.1371/journal.pone.0043683. Epub 2012 Aug 31.

17.

Ephrin-B2-activated peripheral blood mononuclear cells from diabetic patients restore diabetes-induced impairment of postischemic neovascularization.

Broquères-You D, Leré-Déan C, Merkulova-Rainon T, Mantsounga CS, Allanic D, Hainaud P, Contrères JO, Wang Y, Vilar J, Virally M, Mourad JJ, Guillausseau PJ, Silvestre JS, Lévy BI.

Diabetes. 2012 Oct;61(10):2621-32. Epub 2012 May 17.

18.

Bone marrow-derived progenitor cells augment venous remodeling in a mouse dorsal skinfold chamber model.

Doyle ME, Perley JP, Skalak TC.

PLoS One. 2012;7(2):e32815. doi: 10.1371/journal.pone.0032815. Epub 2012 Feb 28.

19.

Molecular imaging of bone marrow mononuclear cell survival and homing in murine peripheral artery disease.

van der Bogt KE, Hellingman AA, Lijkwan MA, Bos EJ, de Vries MR, van Rappard JR, Fischbein MP, Quax PH, Robbins RC, Hamming JF, Wu JC.

JACC Cardiovasc Imaging. 2012 Jan;5(1):46-55. doi: 10.1016/j.jcmg.2011.07.011.

20.

Efficient non-viral integration and stable gene expression in multipotent adult progenitor cells.

Wilber A, Ulloa Montoya F, Hammer L, Moriarity BS, Geurts AM, Largaespada DA, Verfaillie CM, McIvor RS, Lakshmipathy U.

Stem Cells Int. 2011;2011:717069. doi: 10.4061/2011/717069. Epub 2011 Oct 2.

Supplemental Content

Support Center